TrialClinical cancer research : an official journal of the American Association for Cancer Research2015

Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide.

Peter H O'Donnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.